Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this video charting update.
Share Talk Bulletin Board Heroes, Tuesday 20th October 2020
Stock Market Watch: AMC, BZT, XTR, N4P, TOOP, FCCN, DEST & INX
Stocks that may or may not make the grade in the papers
Share Talk Bulletin Board Heroes, Wednesday 7th October 2020
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this video charting update.
Stock Market Watch: ORPH, CGNR, AMGO, THR, N4P & ALBA
Shares of fast growing pharma services group Open Orphan (ORPH) soared 27%, following not only the announcement of a new contract win for its Venn Life Sciences subsidiary with a major European
Share Talk Bulletin Board Heroes, Wednesday 23rd September 2020
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this video charting update.
Share Talk Weekly Stock Market News, Sunday 20th September 2020
Welcome to the Share Talk Weekly Newsletter as we look back at the week that was.
N4 Pharma PLC (N4PL) Covid-19 Proof of Concept Update
Covid-19 Proof of Concept Update and move to in vivo study
Share Talk Weekly Stock Market News, Sunday 6th September 2020
Another week of more highs than lows across the small-cap markets, we are losing count of companies we are highlighting that hit a new 52 wk high.
TPI provides its latest research note on N4 Pharma plc (N4P.L).
N4P has announced the appointment of Ardena Holding NV (‘Ardena’) as its contract development and manufacturing organisation (‘CDMO’) partner for the technology transfer and upscaling manufacture of Nuvec®, the Group’s unique silica nanoparticle
Share Talk Bulletin Board Heroes, Tuesday 1st September 2020
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this video charting update.
N4 Pharma PLC (N4P.L) Technology Transfer and Manufacturing Contract
N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing, a novel delivery system for cancer treatments and vaccines, announces that it has appointed the API and Nanomedicines business unit
